Rocket Lab Stock: Why It Crashed 36% and Is Now Rebounding
Rocket Lab (NASDAQ: RKLB) saw its share price plummet 36.1% in July, according to data from S&P Global Market Intelligence, before staging a robust recovery in August driven by major…
Rocket Lab (NASDAQ: RKLB) saw its share price plummet 36.1% in July, according to data from S&P Global Market Intelligence, before staging a robust recovery in August driven by major…
Life360 reported its second-quarter financial results, underscoring the company’s ongoing performance and operational trajectory within the digital safety and location-sharing market. The Freemium Business Model Central to Life360’s market strategy…
JFrog (NASDAQ: FROG) shares surged 7.6% during afternoon trading today after the software supply chain platform reported second-quarter financial results that exceeded analyst expectations and included a raised full-year outlook.…
Getty Images (NYSE:GETY) shares tumbled 15.2% following a disappointing second-quarter 2026 performance, where the company reported $229.1 million in revenue—a 2.5% year-over-year decline that missed analyst expectations. Beyond the revenue…
AI cloud infrastructure provider CoreWeave is set to release its second-quarter financial results this Tuesday after market close, facing intense scrutiny over massive capital expenditures and shrinking profit margins. Rising…
Elena Gomez, President and CFO of Toast, Inc. (NYSE:TOST), sold 17,076 shares of Class A Common Stock between August 5 and August 6, according to a recent SEC Form 4…
Gartner (IT) is aggressively repurchasing shares—retiring over 41% of its stock since 2015—to bolster earnings per share, even as the firm faces potential disruption from AI-driven research tools and tightened…
Virginia regulators have ordered Dominion Energy to draft a new policy requiring data centers to cover the costs of grid upgrades specifically built to serve their facilities, a move designed…
F&G Annuities & Life (FG) shares have dipped 15.8% over the past year, but recent valuation metrics suggest the market may be undervaluing the company’s intrinsic worth following its Q2…
CareDx (CDNA), a commercial-stage firm valued at $2.42 billion, has seen its stock price skyrocket by 300% over the past year, driven by its specialized diagnostic surveillance solutions for heart…